Vision Monday


Dr. Robert Greenberg Resigns From Second Sight’s Board

By Staff
Wednesday, April 11, 2018 12:15 AM

LOS ANGELES—Second Sight Medical Products (NASDAQ:EYES), which makes retinal and cortical prostheses, announced that Robert Greenberg, MD, PhD has resigned from its board of directors and the company, effective April 3, 2018. Dr. Greenberg has served on the board since May 2003, as chief executive officer from December 1998 to August 2015, and as chairman of the board from August 2015 to March 2018. Will McGuire, president and chief executive officer of Second Sight, based here, said, “I have enjoyed working with Bob to advance Second Sight’s breakthrough technologies and bring them to market worldwide. Second Sight has benefited from his deep clinical insights and extensive industry and technical knowledge.

“On behalf of the entire management team, we sincerely appreciate his contributions over the years toward achieving Second Sight’s mission of treating nearly all forms of blindness and wish him well. As we move forward, I am confident that we have the right team in place to execute upon our R&D and clinical programs,” he said.

“I would like to thank the past and current employees of Second Sight, our many partners, most importantly, the patient volunteers, and the investors who have supported our mission to help the blind to once again see,” said Dr. Greenberg.
Also Recommended
CEI Vision Partners Acquires Dayton-Based Ophthalmology Practice
OptiSource Acquires New York Eye’s Eyeglass Case Division
National Vision Asks Student Grant Applicants to Consider Public Health Issues
Altris.AI and Huvitz to Collaborate on AI for Retinal Diagnosis
Home VM Mobile